SCHEMBL3972432

SCHEMBL3972432

COc1ccc(C(C(=O)O)C2(O)CCCC2)cc1Br

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
CYP1A2 P05177 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP2D6 P10635 1/20 0.42
HPGD P15428 1/20 0.42
GAA P10253 2/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 2/20 0.39
HDAC1 Q13547 1/20 0.39
NPC1 O15118 1/20 0.39
RECQL P46063 1/20 0.39
LMNA P02545 4/20 0.38
MAPT P10636 2/20 0.38
ALOX12 P18054 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3972623 0.99 ALDH1A1 (0.42) ALDH1A1CYP1A2CYP2C19CYP2D6HPGD
SCHEMBL3957196 0.99 ALDH1A1 (0.42) ALDH1A1CYP1A2CYP2C19CYP2D6HPGD
SCHEMBL3954998 0.89 KMT2A (0.45) ALDH1A1CYP1A2CYP2C19CYP2D6HPGD
SCHEMBL3960319 0.85 ALDH1A1 (0.37) ALDH1A1CYP1A2CYP2C19CYP2D6HPGD
SCHEMBL4366829 0.83 LMNA (0.41) ALDH1A1GAALMNAMAPTCHRM2
SCHEMBL4361002 0.77 ALDH1A1 (0.41) ALDH1A1HPGDGAAPKMRAB9A
SCHEMBL3977775 0.77 LMNA (0.39) ALDH1A1GAAPKMRAB9ANPC1
SCHEMBL3958117 0.77 MEN1 (0.51) ALDH1A1HPGDGAAPKMRAB9A
SCHEMBL3956781 0.77 KMT2A (0.43) ALDH1A1GAAPKMRAB9ANPC1
SCHEMBL3953035 0.77 KMT2A (0.41) ALDH1A1GAARAB9AHDAC1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531543-B2 Phenylpiperazine cycloalkanol derivatives and methods of their use WYETH (US) 2009-05-12 US disclosed
EP-1673358-A1 PHENYLPIPERAZINE CYCLOALKANOL DERIVATIVES AND METHODS OF THEIR USE Wyeth (US) 2006-06-28 EP disclosed
US-20050143394-A1 Phenylpiperazine cycloalkanol derivatives and methods of their use WYETH (US) 2005-06-30 US disclosed
WO-2005037808-A1 PHENYLPIPERAZINE CYCLOALKANOL DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143394-A1 Phenylpiperazine cycloalkanol derivatives and methods of their use HTR5A, PNMT, HTR3A ALDH1A1 1206/4885CYP1A2 223/4885CYP2C19 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.